Navigation Links
Data Suggests Positive Pharmacokinetic Results From Phase I Research of Extended-Release Topiramate
Date:12/6/2010

sma concentration than IR topiramate.  

"We are excited about the progress we have made in our development of USL255 and encouraged that USL255 may offer an improved PK profile compared with IR topiramate," Halvorsen added.  "We are committed to the development of USL255 for patients with refractory partial-onset seizures as part of USL's ongoing commitment to become a leader in providing therapies that empower people suffering from CNS diseases to lead healthy, productive lives."

In a related development, Upsher-Smith recently announced the addition of an open-label extension study of its ongoing global Phase III clinical trial (PREVAIL) for USL255.  The Phase III clinical trial is currently being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA).

Upsher-Smith's Expanding CNS Pipeline

USL255 is the lead investigational drug in Upsher-Smith's expanding central nervous system (CNS) development pipeline, with an anticipated indication for the adjunctive treatment of adult epilepsy patients with partial onset seizures (POS).  USL's pipeline includes a number of other investigational drug programs.  Another program in this pipeline, USL261 (nasal midazolam) is under development for the management of increased bouts of seizure activity, including acute repetitive seizures and seizure clusters, in epilepsy.  Other programs include USL260 (tonabersat), an investigational drug and first-in-class neuronal gap junction modulator for the potential treatment of epilepsy.  Upsher-Smith has previously announced its partnership with Proximagen Group Plc for the PRX1 program for the symptomatic treatment of Parkinson's disease, in which Upsher-Smith is responsible for the world-wide development and commercialization of PRX1 under the direction of a joint steering committee on which there is representation of both Upsher-Smith and Proximagen.


'/>"/>

SOURCE Upsher-Smith
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
3. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
4. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
5. New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly
6. Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimers Disease
7. MitraClip Device Preliminary Data Suggests Improved Heart Function and Relief from Heart Failure Symptoms in Functional Mitral Regurgitation Patients
8. New Gene Discovery Suggests Which Patients CTIs Brostallicin May Benefit
9. New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery
10. New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR
11. Study Suggests a Possible Way to Offset Chemobrain Memory Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... ATLANTA , Nov. 18, 2014   Rio ... partnership with University of Texas Health Science Center ... Brownsville , has selected Wellcentive,s suite ... empower providers in a four-county area to partner with ... the health of their Medicaid and uninsured patient populations, ...
(Date:11/18/2014)... Calif. , Nov. 17, 2014   ... Products Inc. (OTC: GWPC) is a diversified company. ... and convenience of advanced technology and proven expertise ... fundamental business of health and wellness.  WholeHEALTH Products, ... hospitals, doctors, clinics and healthcare centers, and 8 ...
(Date:11/18/2014)... N.J. , Nov. 18, 2014  A new ... countries finds that a large majority of the general ... cancer (84%), a devastating disease that is responsible for ... prostate cancers combined 1,2,4 . The "Any One Any ... understanding about the widespread impact of lung cancer, but ...
Breaking Medicine Technology:Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 2Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 3Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 4WholeHEALTH Product Inc. to File FDA Emergency Use Approval (EUA) for PCR Rapid Ebola Test 2Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 2Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 3Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 4Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 5Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 6
... Pharmaceuticals announced today that it has filed its first ... Drug Administration (FDA).  The recently filed product has been ... seven years of market exclusivity. In addition, the FDA ... primarily due to the safety advantages it offers. Fast ...
... that a new market research report is available in its ... Latin America http://www.reportlinker.com/p0192647/The-Outlook-for-Medical-Devices-in-Latin-America.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Brazil Chile Colombia ... Peru Venezuela The ...
Cached Medicine Technology:Arbor Pharmaceuticals Announces Filing of First NDA 2The Outlook for Medical Devices in Latin America 2The Outlook for Medical Devices in Latin America 3The Outlook for Medical Devices in Latin America 4
(Date:11/18/2014)... CA (PRWEB) November 18, 2014 As ... new routines, many people look at fall as the ... Dr. Kevin Sadati , Orange County facial plastic ... Newport Beach practice. At the Gallery of Cosmetic ... taking advantage of his non-invasive cosmetic surgery procedures. ...
(Date:11/18/2014)... Haelle HealthDay Reporter MONDAY, ... experience a severe abusive head trauma before the age of ... new study. In addition, among those who survive ... the study found. Abusive head trauma includes shaken baby ... suffers head injuries, according to background information in the study. ...
(Date:11/18/2014)... Dennis Thompson ... News) -- Daily low-dose aspirin therapy may not have ... The study, which involved more than 14,000 ... difference in heart-related deaths or non-fatal heart attacks and ... didn,t. "It indicates that primary prevention with ...
(Date:11/18/2014)... HealthDay Reporter , MONDAY, Nov. ... can safely take aspirin combined with a blood-thinning medication, new ... patient,s risk of early death, according to a new study ... Association in Chicago. The report was also published online Nov. ... from more than a dozen clinical trials revealed no increase ...
(Date:11/18/2014)... 17, 2014 (HealthDay News) -- Until recently, insect-transmitted Chagas disease ... it has made its way to the United States over ... is typically transmitted via the bite of the "kissing bug," ... now a new study suggests that common bedbugs might be ... acquire and transmit the parasite. Our next step is to ...
Breaking Medicine News(10 mins):Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 4Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 2Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 3Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 3
... , , , DURHAM, ... announced that company chairman and CEO, Chris Stern, will present at an ... The presentation will be at the Zurich Airport Radisson Hotel and ... webcast but will be open to interested investors. , ...
... WESTFORD, Mass., Sept. 22 Cynosure, Inc. (Nasdaq: ... array of light-based aesthetic treatment systems, today announced that President and ... will present at the third annual Maxim Group Growth Conference in ... will be webcast live over the Internet beginning at 10:00 a.m. ...
... may have boosted seniors, sexually transmitted infection rates, researchers ... widowers who recently lost their wives are more likely ... who are still married, a new study has found. ... drugs like Viagra could boost the risk, noting the ...
... , , SEATTLE, Sept. 22 ... firms, announced today that it has opened a new office in ... offices, will continue to serve existing clients while expanding the range ... "Milliman,s wide range of talents and sixty-plus years of experience ...
... , , MOUNTAIN ... in devices for clot removal in ischemic stroke patients, today announced ... DAC catheters are a first-in-class family of devices used to provide ... and other neurovascular procedures. , , The ...
... , PITTSBURGH, Sept. 22 Cohera Medical, ... the ISO 13485:2003 International Standard for the Design, Development, ... certification allows Cohera Medical to proceed with the CE ... novel internal surgical adhesive, upon completion of development for ...
Cached Medicine News:Health News:Cynosure to Present at the Maxim Group Growth Conference 2Health News:Sex With New Partners Raises Widowers' Disease Risk 2Health News:Milliman Announces the Opening of a New Office in San Juan, Puerto Rico 2Health News:Concentric Medical Launches Full Family of DAC(TM) Neurovascular Catheters 2Health News:Cohera Medical Receives ISO 13485 Certification: Company Meets International Standards for Design, Development and Manufacturing of Medical Devices 2
... D.O.R.C. Intraocular Electromagnet offers a truly unique ... intraocular foreign bodies (IOFB). Other magnets are ... offers an intraocular electromagnet for use through ... surgical technique. The D.O.R.C. Intraocular Electromagnet offers ...
... The new SureSigns VS1 ... vital signs monitor that provides ... seconds. The VS1 is designed ... with features like large, bright, ...
... continuous monitoring, the M3 and M4 monitors ... neonatal patient care. M Series monitors are ... a basic set of non-invasive parameters and ... Multi-Measurement Server extensions offer Mainstream or Microstream® ...
Compact networked patient monitors for flexible care....
Medicine Products: